Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania

Archives of Virology

Volumn 152, Issue 4, 2007, Pages 727-738

  Combiescu, M ^a   Guillot, S ^b   Persu, A ^a   Baicus, A ^a   Pitigoi, D ^c   Balanant, J ^b   Oprisan, G ^a   Crainic, R ^b   Delpeyroux, F ^b   Aubert Combiescu, A ^a  

^a CANTACUZINO INSTITUTE   (Romania)

^b INSTITUT PASTEUR   (France)

^c Ministry of Health   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; ORAL POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG; VP1 PROTEIN, POLIOVIRUS;

ANIMAL; ARTICLE; CASE REPORT; CELL LINE; CLASSIFICATION; DISEASE MODEL; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MALE; MOUSE; PATHOGENICITY; PHYLOGENY; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; QUADRIPLEGIA; ROMANIA; SEQUENCE HOMOLOGY; TRANSGENIC MOUSE; VIROLOGY; VIRUS GENOME;

ANIMALS; CAPSID PROTEINS; CELL LINE; CHILD, PRESCHOOL; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOME, VIRAL; HUMANS; INFANT; MALE; MICE; MICE, TRANSGENIC; PHYLOGENY; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; QUADRIPLEGIA; ROMANIA; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID;

MIRIDAE; MUS MUSCULUS; POLIOVIRUS;

EID: 33947411412     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-006-0884-y     Document Type: Article

References (61)

1. R Abraham P Minor G Dunn JF Modlin PL Ogra 1993 Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine J Infect Dis 168 1105 1109
2. F Assad WC Cockburn 1982 The relation between acute persisting paralysis and poliomyelitis vaccine-results of a ten year inquiry Bull WHO 60 231 238
3. J Balanant S Guillot A Candrea F Delpeyroux R Crainic 1991 The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay Virology 184 645 654
4. S Blomqvist AL Bruu M Stenvik T Hovi 2003 Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccine and containing a chimeric capsid protein VP1 J Gen Virol 84 573 580
5. S Blomqvist C Savolainen P Laine P Hirttio E Lamminsalo E Penttila S Joks M Roivainen T Hovi 2004 Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia J Virol 78 4876 4883
6. MJ Bouchard DH Lam VR Racaniello 1995 Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin strain J Virol 69 4972 4978
7. G Buttinelli V Donati S Fiore J Marturano A Plebani P Balestri R Soresina R Vivarelli F Delpeyroux J Martin L Fiore 2003 Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis J Gen Virol 84 1215 1221
8. N Cammack A Phillips G Dunn V Patel PD Minor 1988 Intertypic genomic rearrangements of poliovirus strains in vaccines Virology 167 507 514
9. Centers for Disease Control and Prevention 2002 Certification of Poliomyelitis Eradication - European Region Morbid Mortal Wkly Rep 51 572 574
10. EA Cherkasova EA Korotkova ML Yakovenko OE Ivanova TP Eremeeva KM Chumakov VI Agol 2002 Long-term circulation of vaccine-derived poliovirus that causes paralytic disease J Virol 76 6791 6799
11. EA Cherkasova M Laassri V Chizhikov E Korotkova E Dragunsky VI Agol K Chumakov 2003 Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses Proc Natl Acad Sci USA 100 9398 9403
12. EA Cherkasova ML Yakovenko GV Rezapkin EA Korotkova OE Ivanova TP Eremeeva LI Krasnoproshina NI Romanenkova NR Rozaeva L Sirota VI Agol KM Chumakov 2005 Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child, an insight into the natural evolution of oral polio vaccine J Virol 79 1062 1070
13. C Christodoulou F Colbere-Garapin A Macadam LF Taffes S Marsden PD Minor F Horaud 1990 Mapping of mutations associated with monkey neurovirulence of Sabin 1 poliovirus revertants selected at high temperature J Virol 64 4922 4929
14. PD Cooper 1997 Genetics of picornaviruses Comp Virol 9 133 207
15. NS Cuervo S Guillot N Romanenkova M Combiescu AA Combiescu M Seghier V Caro R Crainic F Delpeyroux 2001 Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccines J Virol 75 5740 5751
16. Felsenstein J (1993) PHYLIP (Phylogeny Interference Package), version 3.5c. Department of genetics, University of Washington, Seattle, Washington
17. M Furione S Guillot D Otelea J Balanant A Candrea R Crainic 1993 Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis Virology 196 199 208
18. GV Gavrilin EA Cherkasova GY Lipskaya OM Kew VI Agol 2000 Evolution of circulating wild poliovirus and vaccine-derived poliovirus in an immunodeficient patient: a unifying model J Virol 74 7381 7390
19. MM Georgescu F Delpeyroux M Tardy-Panit J Balanant M Combiescu AA Combiescu S Guillot R Crainic 1994 High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis J Virol 68 8089 8101
20. MM Georgescu F Delpeyroux R Crainic 1995 Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus J Gen Virol 76 2343 2348
21. MM Georgescu M Tardy-Panit S Guillot R Crainic F Delpeyroux 1995 Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus J Virol 69 138 142
22. MM Georgescu J Balanant A Macadam D Otelea M Combiescu AA Combiescu R Crainic F Delpeyroux 1997 Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis J Virol 71 7758 7768
23. S Guillot D Otelea F Delpeyroux R Crainic 1994 Point mutation involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction Vaccine 12 503 507
24. S Guillot V Caro N Cuervo E Korotkova M Combiescu A Persu AA Combiescu F Delpeyroux R Crainic 2000 Natural genetic exchanges between vaccine and wild poliovirus strains in humans J Virol 74 8434 8443
25. H Horie H Yoshida K Matsuura M Miyazawa Y Ota T Nakayama Y Doi S Hashizume 2002 Neurovirulence of type 1 polioviruses isolated from sewage in Japan Appl Environ Microbiol 68 138 142
26. BP Hull WR Dowdle 1997 Poliovirus surveillance: building the global Polio Laboratory Network J Infect Dis 175 Suppl 1 S1136
27. OM Kew BK Nottay 1984 Evolution of the oral polio vaccine strains in humans occurs by both mutation and intramolecular recombination R Lerner R Chanock Modern approaches to vaccines Cold Spring Harbor Press Cold Spring Harbor, N.Y. 357 362
28. OM Kew V Morris-Glasgow M Landaverde C Burns J Shaw Z Garib J André E Blackman CJ Freeman J Jorba R Sutter G Tambini L Venczel C Pedreira F Laender H Shimizu T Yoneyama T Miyamura H van der Avoort MS Oberste D Kilpatrick S Cochi M Pallansch C de Quadros 2002 Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus Science 296 356 359
29. DR Kilpatrick B Nottay CF Yang 1996 Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy J Clin Microbiol 34 2990 2996
30. AMQ King 1988 Preferred sites of recombination in poliovirus RNA: an analysis of 40 intertypic cross-over sequences Nucleic Acids Res 16 11705 11723
31. J Li T Yoneyama H Yoshida K Yoshii H Shimizu T Miyamura M Hara X-H Hou H Zheng Y Fang L-B Zhang A Hagiwara 1995 Genetic analysis of wild type 1 poliovirus isolates in China, 1985-1993 Res Virol 146 415 422
32. J Li L-B Zhang T Yoneyama H Yoshida H Shimizu K Yoshii M Hara T Nomura H Yoshikura T Miyamura A Hagiwara 1996 Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients Arch Virol 141 1047 1054
33. GY Lipskaya AR Muzychenko OK Kutitova SV Maslova M Equestre SG Drozdov R Perez Bercoff VI Agol 1991 Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases J Med Virol 35 290 296
34. J Martín E Samoilovich G Dunn A Lackenby E Feldman A Heath E Svirchevskaya G Cooper M Yermalovich PD Minor 2002 Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis J Virol 76 10921 10928
35. J Martin K Odoom G Tuite G Dunn N Hopewell G Cooper C Fitzharris K Butler WW Hall PD Minor 2004 Long-term excretion of vaccine-derived poliovirus by a healthy child J Virol 78 13839 13847
36. CD Mendelsohn E Wimmer VR Racaniello 1989 Cellular receptor for poliovirus: molecular cloning, nucleotide sequencing, and expression of a new member of the immunoglobulin superfamily Cell 56 85565
37. PD Minor G Dunn 1988 The effect of sequences in the 5′ non-coding region on the replication of polioviruses in the human gut J Gen Virol 69 1091 1096
38. PD Minor 1992 The molecular biology of poliovirus in poliovaccines J Gen Virol 73 3065 3077
39. JH Nakano MH Hatch ML Thieme B Nottay 1978 Parameters for differentiating vaccine-derived and wild poliovirus strains Prog Med Virol 24 178 206
40. BM Nkowane SGF Wassilak WA Orenstein 1987 Vaccine-associated paralytic poliomyelitis: United States 1973 through 1984 JAMA 257 1335 1340
41. A Nomoto I Arita 2002 Eradication of poliomyelitis Nat Immunol 3 205 208
42. D Otelea S Guillot M Furione AA Combiescu J Balanant A Candrea R Crainic 1993 Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses Dev Biol Stand 78 33 38
43. PA Pipkin DJ Wood VR Racaniello PD Minor 1993 Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro J Virol Methods 41 330 340
44. D Rousset M Rakoto-Andrianarivelo R Razafindratsimandresy 2003 Recombinant-vaccine-derived poliovirus in Madagascar Emerg Infect Dis 9 885 887
45. AB Sabin LR Boulger 1973 History of Sabin attenuated poliovirus oral live vaccine strains J Biol Stand 1 115 118
46. AB Sabin 1985 Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world J Infect Dis 151 420 436
47. J Sambrook EF Fritsch T Maniatis 1989 Molecular cloning: a laboratory manual 2 1 Cold Spring Harbor Laboratory Press Cold Spring Harbor, N.Y.
48. H Shimizu B Thorley FJ Paladin KA Brussen V Stambos L Yuen A Utama Y Tano M Arita H Yoshida T Yoneyama A Benegas S Roesel M Pallansch O Kew T Miyamura 2004 Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001 J Virol 78 13512 13521
49. LM Shulman Y Manor R Handsher F Delpeyroux MJ [tmp] McDonough T Halmut I Silberstein J Alfandari J Quay T Fisher J Robinov OM Kew R Crainic E Mendelson 2000 Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel J Clin Microbiol 38 3729 3734
50. PM Strebel RW Sutter SL Cochi RJ Biellik EW Brink OM Kew A Pallansch WA Orenstein AR Hinman 1992 Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease Clin Infect Dis 14 568 579
51. PM Strebel AA Combiescu NN Ion MS Biberi M Combiescu RW Sutter OM Kew MA Pallansch PA Patriarca SL Cochi 1994 Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine associated disease and reintroduction of wild-virus infection Am J Epidemiol 140 1111 1124
52. RW Sutter OM Kew SL Cochi 2003 Poliovirus vaccine-live SA Plotkin WA Orenstein Vaccines 4 Saunders Philadelphia 651 705
53. RW Sutter VM Caceres P Mas Lago 2004 The role of routine polio immunization in the post-certification era Bull WHO 82 31 41
54. M Tardy-Panit B Blondel A Martin F Tekaia F Horaud F Delpeyroux 1993 A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice J Virol 67 4630 4638
55. JD Thompson DG Higgins TJ Gibson 1994 CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice Nucleic Acids Res 22 4673 4680
56. DJ Wood AJ Macadam 1997 Laboratory tests for live attenuated poliovirus vaccines Biologicals 25 3 15
57. World Health Organization (1997/2004) Polio laboratory manual WHO/IVB/04.10 World Health Organization, Geneva, Switzerland
58. World Health Organization 1988 Expanded Programme on Immunization. Global eradication of poliomyelitis by the year 2000 Wkly Epidemiol Rec 63 161 162
59. World Health Organization 2003 Progress towards the global eradication of poliomyelilis, 2002 Wkly Epidemiol Rec 78 138 144
60. World Health Organization (2003) Global Polio eradication initiative Strategic Plan 2004-2008. WHO
61. C-F Yang T Naguib S-J Yang E Nasr J Jorba N Ahmed R Campagnoli H van der Avoort H Shimizu T Yoneyama T Miyamura MA Pallansch O Kew 2003 Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 J Virol 77 8366 8377